Aptose Biosciences
APTO
#10447
Rank
C$6.06 M
Marketcap
C$2.37
Share price
0.00%
Change (1 day)
681.30%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -C$28.98 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$35.03 Million, an increase over its 2023 earnings that were of -C$72.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$28.98 Million-17.28%
2024 -C$35.03 Million-51.82%
2023 -C$72.72 Million22.9%
2022 -C$59.17 Million-34.91%
2021 -C$90.9 Million17.36%
2020 -C$77.46 Million107.65%
2019 -C$37.3 Million-7.73%
2018 -C$40.43 Million160.68%
2017 -C$15.51 Million-20.27%
2016 -C$19.46 Million28.71%
2015 -C$15.12 Million
2013 -C$8.57 Million
2010 -C$7.3 Million-8.31%
2009 -C$7.96 Million
2006 -C$14.76 Million-156.93%
2005 C$25.91 M-185.16%
2004 -C$30.43 Million458.58%
2003 -C$5.45 Million-63.66%
2002 -C$14.99 Million-8.04%
2001 -C$16.3 Million16.73%
2000 -C$13.97 Million294.99%
1999 -C$3.54 Million-6.51%
1998 -C$3.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-C$47.26 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-C$93.76 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-C$87.19 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA